1. Home
  2. HOTH vs FBGL Comparison

HOTH vs FBGL Comparison

Compare HOTH & FBGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOTH
  • FBGL
  • Stock Information
  • Founded
  • HOTH 2017
  • FBGL 1996
  • Country
  • HOTH United States
  • FBGL Singapore
  • Employees
  • HOTH N/A
  • FBGL N/A
  • Industry
  • HOTH Biotechnology: Pharmaceutical Preparations
  • FBGL Miscellaneous manufacturing industries
  • Sector
  • HOTH Health Care
  • FBGL Consumer Discretionary
  • Exchange
  • HOTH Nasdaq
  • FBGL Nasdaq
  • Market Cap
  • HOTH 8.3M
  • FBGL 8.4M
  • IPO Year
  • HOTH 2019
  • FBGL 2025
  • Fundamental
  • Price
  • HOTH $1.14
  • FBGL $0.60
  • Analyst Decision
  • HOTH Strong Buy
  • FBGL
  • Analyst Count
  • HOTH 3
  • FBGL 0
  • Target Price
  • HOTH $4.00
  • FBGL N/A
  • AVG Volume (30 Days)
  • HOTH 3.0M
  • FBGL 79.7K
  • Earning Date
  • HOTH 05-12-2025
  • FBGL 01-01-0001
  • Dividend Yield
  • HOTH N/A
  • FBGL N/A
  • EPS Growth
  • HOTH N/A
  • FBGL N/A
  • EPS
  • HOTH N/A
  • FBGL N/A
  • Revenue
  • HOTH N/A
  • FBGL $10,146,582.00
  • Revenue This Year
  • HOTH N/A
  • FBGL N/A
  • Revenue Next Year
  • HOTH N/A
  • FBGL N/A
  • P/E Ratio
  • HOTH N/A
  • FBGL N/A
  • Revenue Growth
  • HOTH N/A
  • FBGL N/A
  • 52 Week Low
  • HOTH $0.58
  • FBGL $0.44
  • 52 Week High
  • HOTH $3.80
  • FBGL $5.45
  • Technical
  • Relative Strength Index (RSI)
  • HOTH 51.11
  • FBGL N/A
  • Support Level
  • HOTH $1.15
  • FBGL N/A
  • Resistance Level
  • HOTH $1.34
  • FBGL N/A
  • Average True Range (ATR)
  • HOTH 0.13
  • FBGL 0.00
  • MACD
  • HOTH -0.02
  • FBGL 0.00
  • Stochastic Oscillator
  • HOTH 19.44
  • FBGL 0.00

About HOTH Hoth Therapeutics Inc.

Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.

About FBGL FBS Global Limited Ordinary Shares

FBS Global Ltd is a green building contractor and an established interior fit-out specialist in institutional, residential, commercial, and industrial building projects. As a green contractor focused on environmentally sound practices, the company aims to bid tenders for green building projects, use green construction methods and green materials for construction projects, including design, supply and installation of ceilings, partitions, timber deck, carpet, acoustic wall paneling, built-in furniture as well as mechanical and electrical services of a building. The company's revenue is derived mainly from the construction contracts and Sales of construction materials.

Share on Social Networks: